Stifel Initiates Coverage On ClearPoint Neuro With Buy Rating, Announces Price Target of $8
Stifel Initiates Coverage On ClearPoint Neuro With Buy Rating, Announces Price Target of $8
Stifel 以買入評級開始對 ClearPoint Neuro 進行報道，宣佈目標股價爲 8 美元
Stifel analyst Mathew Blackman initiates coverage on ClearPoint Neuro (NASDAQ:CLPT) with a Buy rating and announces Price Target of $8.
Stifel分析師馬修·布萊克曼對ClearPoint Neuro(納斯達克：CLPT)的評級為買入，並宣佈目標價為8美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。